Total Payments
$2,982
2024 Payments
$856.36
Companies
14
Transactions
171
Medicare Patients
1,146
Medicare Billing
$113,653
Payment Breakdown by Category
Food & Beverage$2,982 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,982 | 171 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,733 | 103 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $432.75 | 23 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $237.89 | 14 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $227.04 | 10 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $144.26 | 9 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $38.34 | 3 | $0 (2021) |
| Pharmacosmos Therapeutics Inc. | $32.41 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $26.47 | 1 | $0 (2023) |
| Madrigal Pharmaceuticals | $23.88 | 1 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $22.13 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $856.36 | 47 | ABBVIE INC. ($368.15) |
| 2023 | $564.19 | 34 | ABBVIE INC. ($259.36) |
| 2022 | $631.04 | 37 | ABBVIE INC. ($439.69) |
| 2021 | $930.68 | 53 | AbbVie Inc. ($665.99) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: GI | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: LIVER DISEASE | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/30/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: GI | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: GI | ||||||
| 08/14/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: CRITICAL CARE | ||||||
| 08/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 291 | 294 | $144,152 | $28,211 |
| 2022 | 4 | 289 | 289 | $145,580 | $27,811 |
| 2021 | 4 | 287 | 290 | $139,665 | $27,840 |
| 2020 | 4 | 279 | 281 | $128,685 | $29,791 |
Total Patients
1,146
Total Services
1,154
Medicare Billing
$113,653
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 98 | 99 | $47,209 | $9,037 | 19.1% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 68 | 68 | $40,605 | $7,511 | 18.5% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 65 | 67 | $33,796 | $6,350 | 18.8% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 60 | 60 | $22,542 | $5,312 | 23.6% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 128 | 128 | $60,886 | $11,112 | 18.2% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 76 | 76 | $39,075 | $7,457 | 19.1% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 60 | 60 | $36,151 | $6,989 | 19.3% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 25 | 25 | $9,469 | $2,253 | 23.8% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 133 | 134 | $60,791 | $11,462 | 18.9% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 58 | 58 | $33,962 | $6,744 | 19.9% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 65 | 67 | $33,057 | $6,702 | 20.3% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 31 | 31 | $11,856 | $2,932 | 24.7% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 133 | 134 | $58,073 | $13,173 | 22.7% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 62 | 62 | $34,433 | $7,845 | 22.8% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 58 | 59 | $27,195 | $6,198 | 22.8% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 26 | 26 | $8,985 | $2,575 | 28.7% |
About Hollie Shipley, APRN-CRNA
Hollie Shipley, APRN-CRNA is a Nurse Anesthetist, Certified Registered healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/26/2012. The National Provider Identifier (NPI) number assigned to this provider is 1922342351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hollie Shipley, APRN-CRNA has received a total of $2,982 in payments from pharmaceutical and medical device companies, with $856.36 received in 2024. These payments were reported across 171 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,982).
As a Medicare-enrolled provider, Shipley has provided services to 1,146 Medicare beneficiaries, totaling 1,154 services with total Medicare billing of $113,653. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Anesthetist, Certified Registered
- Other Specialties Certified Registered
- Location Tulsa, OK
- Active Since 11/26/2012
- Last Updated 07/21/2022
- Taxonomy Code 367500000X
- Entity Type Individual
- NPI Number 1922342351
Products in Payments
- HUMIRA (Biological) $738.00
- RINVOQ (Biological) $418.77
- ENTYVIO (Biological) $407.10
- SKYRIZI (Biological) $304.80
- XIFAXAN (Drug) $237.89
- DUPIXENT (Biological) $227.04
- Linzess (Drug) $144.26
- CREON (Drug) $132.11
- LINZESS (Drug) $101.90
- OCALIVA (Drug) $38.34
- ZEPOSIA (Drug) $26.47
- GATTEX (Drug) $25.65
- RESMETIROM (Drug) $23.88
- TERLIVAZ (Drug) $22.13
- TREMFYA (Drug) $19.25
- ZENPEP (Drug) $18.39
- Monoferric (Drug) $18.27
- VIBERZI (Drug) $17.03
- MONOFERRIC (Drug) $14.14
- SUTAB (Drug) $13.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Anesthetist, Certified Registered Doctors in Tulsa
Aubrey Ballard, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $3,890
Nurse Anesthetist, Certified Registered $3,890
Xian Zhang, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $2,827
Nurse Anesthetist, Certified Registered $2,827
Ian Whitmarsh, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $1,374
Nurse Anesthetist, Certified Registered $1,374
Jennifer Young, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $1,150
Nurse Anesthetist, Certified Registered $1,150
Mr. Jeffrey Hensley, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $976.68
Nurse Anesthetist, Certified Registered $976.68
Dawn Campbell, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $393.32
Nurse Anesthetist, Certified Registered $393.32